Analyst IMS Investment Management Services Ltd.
Position in ABBV — AbbVie Inc.
CIK 1634208
Tel-aviv, L3
Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$973,595
-$145,391 QoQ
Shares Held
3,869
-24.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,568
of 4,153 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Analyst IMS Investment Management Services Ltd. holds $26,750,918 across 7 Drug Manufacturers - General names. ABBV ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
410,770 | $19,692,313 | |
| 2 | LLY |
ELI LILLY & Co
|
2,047 | $2,455,233 | |
| 3 | JNJ |
Johnson & Johnson
|
8,024 | $2,037,854 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,995 | $1,155,857 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
3,869 | $973,595 | |
| 6 | SNY |
Sanofi
|
5,208 | $222,173 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,693 | $213,893 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $973,595 | 3,869 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,118,986 | 5,145 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $1,092,410 | 4,781 | Shares | Defined | 2026-01-20 | |
| 2025-09-30 | $639,281 | 2,761 | Shares | Defined | 2025-10-20 | |
| 2025-06-30 | $591,199 | 3,185 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $1,172,054 | 5,594 | Shares | Defined | 2025-04-21 | |
| 2024-12-31 | $587,831 | 3,308 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $988,387 | 5,005 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $512,330 | 2,987 | Shares | Defined | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||